Radius-7 is the First Wearable, Tetherless, Noninvasive rainbow®
Monitor

IRVINE, Calif.–(BUSINESS WIRE)–Jun. 28, 2016–
Masimo
(NASDAQ: MASI) announced today FDA 510(k) clearance for Radius-7®
– the first and only wearable, tetherless, noninvasive rainbow®
monitor. Radius-7, which connects to the Root® patient
monitoring and connectivity platform, is now available in the U.S. with
breakthrough Masimo rainbow® technology. With this clearance,
Radius-7 with Root now enables non-invasive monitoring of more than 10
parameters, including, for the first time in a wearable device, total
hemoglobin (SpHb), a breakthro…

Más información: Masimo Announces FDA 510(k) Clearance for Radius-7® with rainbow® Technology, Including Continuous SpHb®